Skip to main content
SpringerLink
Log in

Nirmatrelvir+ritonavir-related AEs in patients with COVID-19 infections

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pannu V, et al. Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database. Annals of Pharmacotherapy : 5 May 2023. Available from: URL: http://doi.org/10.1177/10600280231169256

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nirmatrelvir+ritonavir-related AEs in patients with COVID-19 infections. Reactions Weekly 1957, 11 (2023). https://doi.org/10.1007/s40278-023-39136-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-39136-7

Search

Navigation